It’s time to move on and accept the immuno project was a dead loss , The TAVR is where all the focus need to go , a human trial and then a partnership . No other projects till AHZ sees a nice big pay cheque from whom ever partners up on the TAVR . Hopefully management have learnt the lesson about spreading money to thinly over numerous projects
Ann: Appendix 4C - quarterly, page-22
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.20 |
Change
0.050(0.33%) |
Mkt cap ! $292.1M | |||
| Open | High | Low | Value | Volume |
| $15.35 | $15.35 | $15.00 | $20.60K | 1.351K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 148 | $15.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.00 | 5 | 2 |
View Market Depth
| Last trade - 10.35am 31/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |